IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
Estrogen Receptor Positive
M.D. Anderson Cancer Centermonoclonal_antibodyPhase 2Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 89/ 100
Competitive context
77 Active assets in the Estrogen Receptor Positive cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TAMOXIFEN Dana-Farber Cancer Institute | Phase 4 | BBB |
EXEMESTANE National Cancer Institute (NCI) | Phase 4 | BBB |
Everolimus UNC Lineberger Comprehensive Cancer Center | Phase 4 | BBB |
TAMOXIFEN Dana-Farber Cancer Institute | Phase 4 | BB |
Palbociclib Forward Pharmaceuticals Co., Ltd. | Phase 3 | BB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →